Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and nitroarginine

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with nitroarginine in 1 studies

Compound Research Comparison

Studies
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Trials
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Recent Studies (post-2010)
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Studies
(nitroarginine)
Trials
(nitroarginine)
Recent Studies (post-2010) (nitroarginine)
73083,93511175

Protein Interaction Comparison

ProteinTaxonomy5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide (IC50)nitroarginine (IC50)
Nitric oxide synthase, endothelialBos taurus (cattle)1.2
Nitric oxide synthase, endothelialHomo sapiens (human)0.38
Nitric oxide synthase, brainHomo sapiens (human)1.265
Nitric oxide synthase, brain Rattus norvegicus (Norway rat)4.12
Nitric oxide synthase, inducibleMus musculus (house mouse)0.5
Nitric oxide synthase, inducibleHomo sapiens (human)6.2
Nitric oxide synthase, brainMus musculus (house mouse)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franco-Cereceda, A; Holm, P; Liska, J1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and nitroarginine

ArticleYear
The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
    Cardiovascular research, 1998, Volume: 37, Issue:3

    Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Swine

1998